Long-Term Assets: The sum of all assets classified as non-current.
Ensysce Biosciences, Inc. (ENSC) had Long-Term Assets of $0.11M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.16M |
|
$-2.57M |
|
-- |
|
$1.16M |
|
$3.74M |
|
$-2.58M |
|
$0.01M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.58M |
|
$-2.57M |
|
13.04M |
|
13.04M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$2.85M |
|
$0.11M |
|
|
Long-Term Assets |
$0.11M |
$2.96M |
|
$4.07M |
|
-- |
|
-- |
|
$4.07M |
|
$-1.11M |
|
$-1.11M |
|
$-1.11M |
|
16.23M |
|
| Cash Flow Statement Financials | |
$-5.46M |
|
-- |
|
$1.83M |
|
$4.31M |
|
$0.68M |
|
$-3.63M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.70 |
|
-- |
|
-- |
|
-- |
|
-0.18 |
|
100.00% |
|
-221.28% |
|
-221.28% |
|
-- |
|
-220.81% |
|
-220.79% |
|
$-5.46M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
-- |
|
2.79 |
|
32.22 |
|
231.44% |
|
231.44% |
|
-86.93% |
|
231.44% |
|
$-0.07 |
|
$-0.42 |
|
$-0.42 |
|